439 related articles for article (PubMed ID: 29944095)
21. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.
Gu X; Gao Y; Wang P; Wang L; Peng H; He Y; Liu Y; Feng N
J Control Release; 2021 May; 333():374-390. PubMed ID: 33798666
[TBL] [Abstract][Full Text] [Related]
22. Theranostic application of nanoemulsions in chemotherapy.
Gorain B; Choudhury H; Nair AB; Dubey SK; Kesharwani P
Drug Discov Today; 2020 Jul; 25(7):1174-1188. PubMed ID: 32344042
[TBL] [Abstract][Full Text] [Related]
23. Current advances in nanoformulations of therapeutic agents targeting tumor microenvironment to overcome drug resistance.
Fakhri S; Moradi SZ; Faraji F; Farhadi T; Hesami O; Iranpanah A; Webber K; Bishayee A
Cancer Metastasis Rev; 2023 Sep; 42(3):959-1020. PubMed ID: 37505336
[TBL] [Abstract][Full Text] [Related]
24. Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment.
Hameed S; Bhattarai P; Dai Z
Sci China Life Sci; 2018 Apr; 61(4):380-391. PubMed ID: 29607461
[TBL] [Abstract][Full Text] [Related]
25. Theranostic Probes for Targeting Tumor Microenvironment: An Overview.
Sikkandhar MG; Nedumaran AM; Ravichandar R; Singh S; Santhakumar I; Goh ZC; Mishra S; Archunan G; Gulyás B; Padmanabhan P
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492519
[TBL] [Abstract][Full Text] [Related]
26. Tumor self-responsive upconversion nanomedicines for theranostic applications.
Xu J; Gulzar A; Yang D; Gai S; He F; Yang P
Nanoscale; 2019 Oct; 11(38):17535-17556. PubMed ID: 31553008
[TBL] [Abstract][Full Text] [Related]
27. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
Overchuk M; Zheng G
Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
[TBL] [Abstract][Full Text] [Related]
28. Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.
Sun Y; Li Y; Shi S; Dong C
Molecules; 2021 May; 26(9):. PubMed ID: 34062992
[TBL] [Abstract][Full Text] [Related]
29. Nanomedicines Targeting the Tumor Microenvironment.
Tong R; Langer R
Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
[TBL] [Abstract][Full Text] [Related]
30. Nanomedicine Strategies to Circumvent Intratumor Extracellular Matrix Barriers for Cancer Therapy.
Xu X; Wu Y; Qian X; Wang Y; Wang J; Li J; Li Y; Zhang Z
Adv Healthc Mater; 2022 Jan; 11(1):e2101428. PubMed ID: 34706400
[TBL] [Abstract][Full Text] [Related]
31. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
[TBL] [Abstract][Full Text] [Related]
32. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
Yang S; Gao H
Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
[TBL] [Abstract][Full Text] [Related]
33. Two-dimensional nanomaterials for tumor microenvironment modulation and anticancer therapy.
Wu M; Niu X; Zhang R; Ping Xu Z
Adv Drug Deliv Rev; 2022 Aug; 187():114360. PubMed ID: 35636568
[TBL] [Abstract][Full Text] [Related]
34. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance.
Hu M; Huang L
Adv Drug Deliv Rev; 2022 Apr; 183():114137. PubMed ID: 35143893
[TBL] [Abstract][Full Text] [Related]
35. Mesoporous nanodrug delivery system: a powerful tool for a new paradigm of remodeling of the tumor microenvironment.
Hang Y; Liu Y; Teng Z; Cao X; Zhu H
J Nanobiotechnology; 2023 Mar; 21(1):101. PubMed ID: 36945005
[TBL] [Abstract][Full Text] [Related]
36. Responsive and activable nanomedicines for remodeling the tumor microenvironment.
Zhang Y; Han X; Nie G
Nat Protoc; 2021 Jan; 16(1):405-430. PubMed ID: 33311713
[TBL] [Abstract][Full Text] [Related]
37. Recent advances of polymeric nanoplatforms for cancer treatment: smart delivery systems (SDS), nanotheranostics and multidrug resistance (MDR) inhibition.
Gupta U; Maity D; Sharma VK
Biomed Mater; 2023 Nov; 19(1):. PubMed ID: 37944188
[TBL] [Abstract][Full Text] [Related]
38. Recent advances of redox-responsive nanoplatforms for tumor theranostics.
Chen M; Liu D; Liu F; Wu Y; Peng X; Song F
J Control Release; 2021 Apr; 332():269-284. PubMed ID: 33662455
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy.
Zhen W; Weichselbaum RR; Lin W
Adv Mater; 2023 May; 35(21):e2206370. PubMed ID: 36524978
[TBL] [Abstract][Full Text] [Related]
40. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
